Showing results (331-340 of 367) with videos related to

Sort By:
Pageof 37
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional TrialJason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Blood Cancer Discovery|June 16, 2022
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome ProgressionAndrew J Menssen, Ajay Khanna, Christopher A Miller, et al.
Blood|October 24, 2015
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemiaJane E Churpek, Khateriaa Pyrtel, Krishna-Latha Kanchi, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Eclinicalmedicine|May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
The New England Journal of Medicine|October 19, 2012
Peripheral-blood stem cells versus bone marrow from unrelated donorsClaudio Anasetti, Brent R Logan, Stephanie J Lee, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
The New England Journal of Medicine|March 16, 2012
Clonal architecture of secondary acute myeloid leukemiaMatthew J Walter, Dong Shen, Li Ding, et al.
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Pageof 37